SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer progression
- 7 December 2024
- journal article
- research article
- Published by Springer Nature in Oncogene
- p. 1-15
Abstract
The epidermal growth factor receptor (EGFR) signaling pathway is frequently associated with ovarian cancer (OC) progression. However, inhibition of EGFR signaling in OC patients achieved limited therapeutic effects, highlighting the need to define the mechanism of EGFR deregulation in OC development. Herein we showed that serine palmitoyltransferase long chain base subunit 2 (SPTLC2) acts as a positive regulator in the EGFR signaling pathway in OC. Phenotypically, depletion of SPTLC2 suppressed clonogenic growth and migration of OC cells in vitro and in ovo, as well as metastasis in OC xenograft models, whereas overexpression of SPTLC2 yielded opposite effects. Mechanistically, SPTLC2 drives an EGFR-FAK-HBEGF signaling axis via binding with EGFR. Notably, the serine palmitoyltransferase activity of SPTLC2 is critical for regulation of the EGFR-FAK-HBEGF signaling axis and activity in OC progression. Clinically, high SPTLC2 expression is associated with high-grade serous ovarian cancer and metastasis. Collectively, our findings establish an oncogenic role of SPTLC2 in OC growth and progression though upregulation of EGFR signaling and suggest that SPTLC2 represents a potential therapeutic target in EGFR-driven ovarian cancer patients.Keywords
Funding Information
- “1+X” program for Clinical Competency enhancement–Clinical Technical Level Improvement Project of The Second Hospital of Dalian Medical University
- The National Natural Science of Chin
This publication has 47 references indexed in Scilit:
- The role of the ‘sphingoid motif’ in shaping the molecular interactions of sphingolipids in biomembranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2021
- In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulationCancer Letters, 2021
- The Effect of SPTLC2 on Promoting Neuronal Apoptosis is Alleviated by MiR-124-3p Through TLR4 Signalling PathwayNeurochemical Research, 2019
- ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinaseCancer Letters, 2018
- Liver serine palmitoyltransferase activity deficiency in early life impairs adherens junctions and promotes tumorigenesisHepatology, 2016
- Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancerCancer Chemotherapy and Pharmacology, 2014
- Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic CancersMolecular Diagnosis & Therapy, 2014
- Integrin-regulated FAK–Src signaling in normal and cancer cellsCurrent Opinion in Cell Biology, 2006
- Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinomaJournal of Molecular Medicine, 2006
- Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in miceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005